Results 211 to 220 of about 761,074 (261)
Some of the next articles are maybe not open access.

Responsive Regulation

2011
Abstract This chapter focuses on the model of ‘responsive regulation’ proposed by Ian Ayres and John Braithwaite to shift the regulatory enforcement debate away from a stale disputation between the proponents of ‘deterrence’ and ‘compliance’ models of enforcement.
Robert Baldwin   +2 more
openaire   +1 more source

Immune responses regulating the response to vascular injury

Current Opinion in Lipidology, 2010
Immune modulation of neointimal formation after vascular injury has been investigated for several decades but the complexities involved continue to obscure a clearer understanding of the process. The rapidly changing field of immunology makes this knowledge imperative.The review discusses immune factors involved in the response to vascular injury ...
Paul C, Dimayuga   +2 more
openaire   +2 more sources

Immune Response Regulation

1982
During the last years we have learned about cell interactions required to generate effector cells during immune responses. Our knowledge of the cell interactions leading to the production of antibody-forming cells, cells mediating delayed-type hypersensitivity (DTH) reactions and cytotoxic T lymphocytes is advanced because we have been able to study ...
openaire   +2 more sources

Are Regulators Responsive?

Law & Policy, 2006
For decades there has been a trend in regulatory studies to advocate a responsive, tit‐for‐tat, regulatory strategy. However, most of the prominent arguments for this strategy are theoretical and few have tested its effectiveness. Even less tested has been whether or not regulatory inspectors manage to react responsively to the “conduct” of regulatees.
openaire   +2 more sources

Regulation of the Immune Response by Antigen

Science, 2001
How, why, and when specific T and B lymphocytes respond against infection follow explicit rules, but how this can be assessed experimentally depends crucially on the methodology used. In this Viewpoint, we discuss the parameters of receptor specificity and antigen that determine whether an immune response can be accurately measured against model ...
R M, Zinkernagel, H, Hengartner
openaire   +2 more sources

Regulation of the immune response by prostaglandins

Clinical Immunology and Immunopathology, 1980
Of all the arachidonic acid metabolites, only prostaglandin E (PGE) has been shown to have a clear role in the regulation of cellular and humoral immune responses. In cellular immune responses such as T cell proliferation, lymphokine production, and cytotoxicity, PGE usually acts as a feedback inhibor of the response.
J S, Goodwin, D R, Webb
openaire   +2 more sources

Regulations and Responsibilities

Journal AWWA, 2016
Usually you pick up a newspaper and you can't find any articles dealing with drinking water quality and public health. These days, drinking water is on the front page. The crisis in Flint, Mich., is occupying a significant part of the national conversation. Our theme this month is regulation of drinking water quality.
openaire   +1 more source

Regulation of immune responses by neutrophils

Annals of the New York Academy of Sciences, 2014
Neutrophils, the most abundant circulating cells in humans, are major pathogen‐killing immune cells. For many years, these cells were considered to be simple killers at the “bottom” of immune responses. However, recent studies have revealed more sophisticated mechanisms associated with neutrophilic cytotoxic functions, and neutrophils have been shown ...
Jing, Wang, Hisashi, Arase
openaire   +2 more sources

Regulators in the DNA damage response

Archives of Biochemistry and Biophysics, 2016
Maintenance of genome integrity is essential for the proper function of all cells and organisms. In response to both endogenous and exogenous DNA damaging agents, mammalian cells have evolved a delicate system to sense DNA damage, stop cell cycle progression, modulate cell metabolism, repair damaged DNA, and induce programmed cell death if the damage ...
Yunhua, Liu, Yujing, Li, Xiongbin, Lu
openaire   +2 more sources

Responsibility and Regulation

2017
The case against approval requirements is even stronger than the empirical record suggests. When patients die because they knowingly and willingly used a dangerous pharmaceutical, drug manufacturers are not culpable for patients’ deaths because patients consent to the risks associated with dangerous drugs.
openaire   +1 more source

Home - About - Disclaimer - Privacy